Drawing for CELERIS THERAPEUTICS

USPTO serial 79377993

CELERIS THERAPEUTICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HARMON, RAYMOND E
Law office
TMEG LAW OFFICE 103

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CELERIS THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Small molecule chemical substances for making of medicines; chemical small molecule substances for the biochemical industryACTIVE—
005Biochemical small molecule substances for medical useACTIVE—
042Research and development in biochemistry for small molecular substances; verification and development of computer algorithms for the purpose of research and development of small molecular weight organic substances; scientific laboratory services for work with low molecular weight organic substances; biochemical research and development services for small molecular chemical substances; research and development of low molecular weight organic substances (small molecule drugs)ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 1, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 10, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 8, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 30, 2024MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 30, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 13, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 18, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 17, 2024RFRRREFUSAL PROCESSED BY MPU—
Mar 28, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 28, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2024DOCKASSIGNED TO EXAMINER—
Sep 12, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 8, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 7, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance